These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18410277)

  • 1. The activation of ERK1/2 MAP kinases in glioblastoma pathobiology and its relationship with EGFR amplification.
    Lopez-Gines C; Gil-Benso R; Benito R; Mata M; Pereda J; Sastre J; Roldan P; Gonzalez-Darder J; Cerdá-Nicolás M
    Neuropathology; 2008 Oct; 28(5):507-15. PubMed ID: 18410277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
    Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.
    Dobashi Y; Suzuki S; Sugawara H; Ooi A
    Hum Pathol; 2007 Jun; 38(6):914-25. PubMed ID: 17376509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of chromosome 7, chromosome 10 and EGFR gene amplification in glioblastoma multiforme.
    Lopez-Gines C; Cerda-Nicolas M; Gil-Benso R; Pellin A; Lopez-Guerrero JA; Callaghan R; Benito R; Roldan P; Piquer J; Llacer J; Barbera J
    Clin Neuropathol; 2005; 24(5):209-18. PubMed ID: 16167544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.
    Miyanaga T; Hirato J; Nakazato Y
    Neuropathology; 2008 Apr; 28(2):116-26. PubMed ID: 18021194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
    Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of neoadjuvant imatinib in glioblastoma: evaluation of clinical and molecular effects of the treatment.
    Razis E; Selviaridis P; Labropoulos S; Norris JL; Zhu MJ; Song DD; Kalebic T; Torrens M; Kalogera-Fountzila A; Karkavelas G; Karanastasi S; Fletcher JA; Fountzilas G
    Clin Cancer Res; 2009 Oct; 15(19):6258-66. PubMed ID: 19789313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue.
    Lama G; Mangiola A; Anile C; Sabatino G; De Bonis P; Lauriola L; Giannitelli C; La Torre G; Jhanwar-Uniyal M; Sica G; Maira G
    Int J Oncol; 2007 Jun; 30(6):1333-42. PubMed ID: 17487353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic analyses for predictors of radiation response in glioblastoma.
    Shih HA; Betensky RA; Dorfman MV; Louis DN; Loeffler JS; Batchelor TT
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):704-10. PubMed ID: 15978739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary glioblastoma with EGFR amplification and a ring chromosome 7 in a young patient.
    Lopez-Gines C; Cerdá-Nicolás M; Gil-Benso R; Pellin A; López-Guerrero JA; Benito R; del Rey J; Miró R; Roldan R; Barberá J
    Clin Neuropathol; 2006; 25(4):193-9. PubMed ID: 16866301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
    Frederick L; Wang XY; Eley G; James CD
    Cancer Res; 2000 Mar; 60(5):1383-7. PubMed ID: 10728703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas.
    Viana-Pereira M; Lopes JM; Little S; Milanezi F; Basto D; Pardal F; Jones C; Reis RM
    Anticancer Res; 2008; 28(2A):913-20. PubMed ID: 18507036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lead acetate induces EGFR activation upstream of SFK and PKCalpha linkage to the Ras/Raf-1/ERK signaling.
    Wang CY; Wang YT; Tzeng DW; Yang JL
    Toxicol Appl Pharmacol; 2009 Mar; 235(2):244-52. PubMed ID: 19133285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation.
    Zohrabian VM; Forzani B; Chau Z; Murali R; Jhanwar-Uniyal M
    Anticancer Res; 2009 Jan; 29(1):119-23. PubMed ID: 19331140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromogenic in situ hybridization accurately identifies EGFR amplification in small cell glioblastoma multiforme, a common subtype of primary GBM.
    Quezado M; Ronchetti R; Rapkiewicz A; Santi M; Blumenthal DT; Rushing EJ
    Clin Neuropathol; 2005; 24(4):163-9. PubMed ID: 16033132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial.
    Schober R; Bilzer T; Waha A; Reifenberger G; Wechsler W; von Deimling A; Wiestler OD; Westphal M; Kemshead JT; Vega F
    Clin Neuropathol; 1995; 14(3):169-74. PubMed ID: 7671460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.
    Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA
    Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.
    Aghi M; Gaviani P; Henson JW; Batchelor TT; Louis DN; Barker FG
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8600-5. PubMed ID: 16361543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance P receptor in U373 MG human astrocytoma cells activates mitogen-activated protein kinases ERK1/2 through Src.
    Yamaguchi K; Kugimiya T; Miyazaki T
    Brain Tumor Pathol; 2005; 22(1):1-8. PubMed ID: 18095097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.